Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
B-Cell Maturation Antigen(BCMA) Targeted Therapies market report explains the definition, types, applications, major countries, and major players of the B-Cell Maturation Antigen(BCMA) Targeted Therapies market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Five Prime Therapeutics
Sutro Biopharma
Deerfield Partners
Juno Therapeutics
Onyx Pharmaceuticals
Malin Corporation
firstVentury Equity
Eureka Therapeutics
Dana-Farber Cancer Institute
Credit Suisse Securities
Transposagen Biopharmaceuticals
By Type:
Bispecific Antibodies
Antibody Drug Conjugates
Chimeric Antigen Receptor T-Cells
By End-User:
Liver Cancer
Respiratory Cancer
Brain Cancer
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Outlook to 2028- Original Forecasts
-
2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market- Recent Developments
-
6.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market News and Developments
-
6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Deals Landscape
7 B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Materials and Cost Structure Analysis
-
7.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Raw Materials
-
7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Trend of Key Raw Materials
-
7.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Suppliers of Raw Materials
-
7.4 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Rate of Raw Materials
-
7.5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Cost Structure Analysis
-
7.5.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Materials Analysis
-
7.5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Labor Cost Analysis
-
7.5.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Expenses Analysis
8 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Import and Export Analysis (Top 10 Countries)
-
8.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Export by Region (Top 10 Countries) (2017-2028)
9 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bispecific Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Chimeric Antigen Receptor T-Cells Consumption and Growth Rate (2017-2022)
-
9.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Respiratory Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Outlook till 2022
-
10.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.2.2 Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.2.3 Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.2 UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.3 Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.4 Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.5 France B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.6 Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.7 Denmark B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.8 Finland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.9 Norway B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.10 Sweden B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.11 Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.12 Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.3.13 Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.4 South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.5 Pakistan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.6 Bangladesh B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.7 Indonesia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.8 Thailand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.9 Singapore B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.10 Malaysia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.11 Philippines B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.4.12 Vietnam B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.2 Colombia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.3 Chile B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.4 Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.5 Venezuela B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.6 Peru B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.7 Puerto Rico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.5.8 Ecuador B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.6.2 Kuwait B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.6.3 Oman B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.6.4 Qatar B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.6.5 Saudi Arabia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.6.6 United Arab Emirates B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.7.2 South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.7.3 Egypt B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.7.4 Algeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
-
10.8.2 New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (2017-2022)
11 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Competitive Analysis
-
11.1 Five Prime Therapeutics
-
11.1.1 Five Prime Therapeutics Company Details
-
11.1.2 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.1.4 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sutro Biopharma
-
11.2.1 Sutro Biopharma Company Details
-
11.2.2 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.2.4 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Deerfield Partners
-
11.3.1 Deerfield Partners Company Details
-
11.3.2 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.3.4 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Juno Therapeutics
-
11.4.1 Juno Therapeutics Company Details
-
11.4.2 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.4.4 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Onyx Pharmaceuticals
-
11.5.1 Onyx Pharmaceuticals Company Details
-
11.5.2 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.5.4 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Malin Corporation
-
11.6.1 Malin Corporation Company Details
-
11.6.2 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.6.4 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 firstVentury Equity
-
11.7.1 firstVentury Equity Company Details
-
11.7.2 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.7.4 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Eureka Therapeutics
-
11.8.1 Eureka Therapeutics Company Details
-
11.8.2 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.8.4 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Dana-Farber Cancer Institute
-
11.9.1 Dana-Farber Cancer Institute Company Details
-
11.9.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.9.4 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Credit Suisse Securities
-
11.10.1 Credit Suisse Securities Company Details
-
11.10.2 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.10.4 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Transposagen Biopharmaceuticals
-
11.11.1 Transposagen Biopharmaceuticals Company Details
-
11.11.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
11.11.4 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Outlook by Types and Applications to 2028
-
12.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Bispecific Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Chimeric Antigen Receptor T-Cells Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Respiratory Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Outlook to 2028
-
13.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.2.2 Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.2.3 Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.2 UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.3 Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.4 Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.5 France B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.6 Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.7 Denmark B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.8 Finland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.9 Norway B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.10 Sweden B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.11 Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.12 Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.13 Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.4 South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.5 Pakistan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.7 Indonesia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.8 Thailand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.9 Singapore B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.10 Malaysia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.11 Philippines B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.12 Vietnam B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.2 Colombia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.3 Chile B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.4 Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.5 Venezuela B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.6 Peru B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.8 Ecuador B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.2 Kuwait B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.3 Oman B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.4 Qatar B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.7.2 South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.7.3 Egypt B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.7.4 Algeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
-
13.8.2 New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of B-Cell Maturation Antigen(BCMA) Targeted Therapies
-
Figure of B-Cell Maturation Antigen(BCMA) Targeted Therapies Picture
-
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Import by Region (Top 10 Countries) (2017-2028)
-
Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Bispecific Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Global Chimeric Antigen Receptor T-Cells Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure France B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Denmark B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Finland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Norway B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Sweden B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Pakistan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Indonesia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Thailand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Singapore B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Malaysia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Philippines B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Vietnam B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Colombia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Chile B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Venezuela B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Peru B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Ecuador B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table GCC B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure Bahrain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Kuwait B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Oman B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Qatar B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Egypt B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Algeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Country (2017-2022)
-
Figure Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Five Prime Therapeutics Company Details
-
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Sutro Biopharma Company Details
-
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Deerfield Partners Company Details
-
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Juno Therapeutics Company Details
-
Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Onyx Pharmaceuticals Company Details
-
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Malin Corporation Company Details
-
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table firstVentury Equity Company Details
-
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Eureka Therapeutics Company Details
-
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Dana-Farber Cancer Institute Company Details
-
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Credit Suisse Securities Company Details
-
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Table Transposagen Biopharmaceuticals Company Details
-
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Main Business and Markets Served
-
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Portfolio
-
Figure Global Bispecific Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chimeric Antigen Receptor T-Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure France B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Bahrain B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Australia B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
